Insider Transactions in Q3 2022 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,798
-21.79%
|
$33,586
$7.3 P/Share
|
|
Sep 08
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,874
+38.66%
|
-
|
|
Sep 08
2022
|
Peter G Edwards GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,127
-24.37%
|
$7,889
$7.3 P/Share
|
|
Sep 08
2022
|
Peter G Edwards GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+50.0%
|
-
|
|
Sep 08
2022
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,728
-21.49%
|
$33,096
$7.3 P/Share
|
|
Sep 08
2022
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,390
+41.16%
|
-
|
|
Sep 08
2022
|
Jerome Riebman CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,104
-25.4%
|
$35,728
$7.3 P/Share
|
|
Sep 08
2022
|
Jerome Riebman CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,758
+42.35%
|
-
|